Patent Application
20170258392
The present invention relates generally to management, treatment and/or diagnosis performed relative to a narrow body lumen.
For a variety of reasons, occlusions often develop in narrow body lumens (i.e., the channel of a tubular-shaped anatomical structure, such as the fallopian tubes, intestines, and coronary arteries) and have medically-relevant consequences on the body. Conventional techniques employed to maintain the health of fallopian tubes, as an example of a narrow body lumen, are described below.
Fallopian tubes are vessel-like, non-fluid filled structures that extend from the uterus to the ovaries. On average, fallopian tubes measure between eight and ten centimeters in length. The inner diameter of the tube varies significantly depending on the segment of the tube, with a minimum inner diameter of approximately one millimeter and a maximum of six millimeters.
Along the length of the lumen of the fallopian tube millions of microscopic hair-like cilia pulsate in wave-like motions at the rate of hundreds of times per second. This motion assists the egg, delivered from the ovaries during ovulation, in passing through the tube to the uterine cavity. Cells located in the tube's inner lining (endothelium) supply the egg with vital nourishment and provide lubrication along the path. It is within the fallopian tube that the sperm first contacts the egg. If the egg is not fertilized within twenty-four to thirty-six hours of reaching the fallopian tube, the egg deteriorates and is removed from the tube by the body's immune system.
Disease of fallopian tubes often presents as occlusion or thickening of the fallopian tube wall and can be caused by infection as well as scarring. In particular, pelvic inflammatory disease (PID), urinary tract infections (UTI) as well as sexually transmitted infections (STI) may cause severe inflammation that in turn blocks the tube. Endometriosis may also cause occlusion when the uterine lining grows into the fallopian tube. An appendectomy or other abdominal surgery may further similarly lead to occluded fallopian tubes.
Regardless of the manner in which it is formed, an occlusion can lead to a hydrosalpinx, where the tube increases in diameter because it is filled with fluid. The presence of fluid prevents both the egg and sperm from traveling through the fallopian tube, preventing fertilization. It is believed that hydrosalpinx can reduce the success rate of in-vitro fertilization by up to 8%.
In the US alone, there are at least seven million cases of infertility annually and an estimated 25-40% of these cases are caused by fallopian tube occlusion or disease.
Hysterosalpingogram (HSG), a procedure most commonly utilized to diagnose fallopian tube disease, requires a radiologist to inject dye into the uterus under x-ray guidance. The dye enters the fallopian tube through the ostia (openings) located in the uterus. If a woman's fallopian tubes are patent (open), dye will flow into the peritoneal cavity. In order to visualize the fluid path, a series of timed x-rays are taken.
Unfortunately, this procedure suffers from several drawbacks. By way of example, HSG suffers from a high false negative rate of 30% and a high false positive rate of 40% due to tubal spasms or shadow (noise) in the x-rays. This often necessitates further procedures. This high rate of inaccuracy is also partly due to the fact that radiologists are not as intimate with the tortuosity and topography of the fallopian tube as gynecologist or reproductive endocrinologist.
As another example of a drawback, HSG is not conducted in-office by a gynecologist or reproductive endocrinologist, the primary caretaker of the patient, as it necessitates a substantial investment in x-ray capital equipment mostly found in hospitals. The patient typically first visits a gynecologist, who conducts a series of blood tests and determines whether HSG is necessary. If it is deemed necessary, then the patient schedules an appointment with the radiologist to have the HSG procedure administered. At the conclusion of the first procedure, the patient returns either to the gynecologist or reproductive endocrinologist to discuss the results. Because of the high inaccuracy rate associated with the HSG, the patient often returns to the radiologist for a second procedure, creating additional unnecessary costs for both the patient and hospital.
As yet another example, patients often complain of pain and some are allergic to the dye used during the procedure. Furthermore, HSG must be conducted before day 12 of a woman's menstrual cycle because the dye may harm a potential full term pregnancy, which limits options for both doctor and patient and further extends the waiting period for a full infertility diagnosis, which is emotionally taxing to the patient and family
To overcome these drawbacks, different direct visualization techniques have been attempted.
Unfortunately, the wet-paper-towel consistency does not provide adequate tactile feedback to a physician, who navigates catheter 20 through fallopian tube 12. As a result, during the imaging procedure, the physician is not aware of the undue pressure exerted against the fallopian tube, leading to perforation 24. To this end,
Therefore, what is needed is a novel diagnostic and therapeutic system and method which allows for effective maintenance of a narrow body lumen, without suffering from the drawbacks encountered by the current and attempted systems and methods described above.
According to one aspect of the present invention, an apparatus for use in a narrow body lumen includes: an outer shaft portion; a tube receivable within the outer shaft portion; an elongate inflatable body having first and second ends, the first end being sealed to the outer shaft portion and the second end being sealed to the tube; wherein, in an initial configuration, the elongate inflatable body is received in the outer shaft portion, and wherein the tube is slidable relative to the outer shaft portion to evert the elongate inflatable body when the elongate inflatable body moves out of the outer shaft portion.
In at least one embodiment, the apparatus is pressurizable, and pressurization of the apparatus inflates the inflatable body.
In at least one embodiment, the pressurization of the apparatus assists in eversion of the elongate inflatable body out of the outer shaft portion.
In at least one embodiment, the tube is slidable to selectively evert the inflatable body to a partially everted state or a fully everted state.
In at least one embodiment, the tube is a rigid tube, and the apparatus further includes a flexible tube extending from a distal end of the rigid tube.
In at least one embodiment, upon sliding the rigid tube to evert the inflatable body, the flexible tube slides within the inflatable body.
In at least one embodiment, the apparatus further includes a visualization instrument receivable within the tube.
In at least one embodiment, the visualization instrument is slidable relative to the tube.
In at least one embodiment, the visualization instrument is slidable so that a distal end of the visualization instrument extends distally of the inflatable member when in a fully everted configuration.
In at least one embodiment, the apparatus further includes pressurized liquid passing between the tube and the visualization instrument.
In at least one embodiment, the pressurized liquid comprises a therapy formulation.
In at least one embodiment, the pressurized liquid is configured to distend the narrow body lumen to facilitate sliding the visualization instrument relative thereto.
In at least one embodiment, the apparatus further includes a tether interconnecting the flexible tube and the inflatable body.
In at least one embodiment, the apparatus further includes a handle portion, which receives one or more luers, one of which is designed to provide pressure to pressurize the apparatus.
In at least one embodiment, the apparatus further includes a wire luer, which is received by the handle portion and is designed to provide a wire for conveying electrical power and signals to facilitate an imaging function carried out by the imaging portion.
In at least one embodiment, the inflatable body comprises a length to extend from an ostium of a Fallopian tube, beyond a uterotubal junction, when fully everted.
In at least one embodiment, the visualization instrument comprises a fiberscope.
In at least one embodiment, the apparatus further includes a pressure sensor; wherein the pressure sensor is designed to measure pressure being applied against the narrow body lumen and if the measurement of pressure equals or exceeds a predetermined value of pressure, trigger an alert signal.
In another aspect of the present invention, a process of operating on a narrow body lumen includes: pressurizing an apparatus and configuring the apparatus to an initial configuration where an inflatable body partially extends out of a distal end of an outer shaft portion of the apparatus; inserting the partially extending inflatable body into the narrow body lumen; fully everting the inflatable body so that the inflatable body is fully deployed out of the distal end of the outer shaft portion and extends further into the narrow body lumen; and delivering at least one of a visualization instrument and therapy through an opening in the inflatable body, distally thereof and into the narrow body lumen.
In at least one embodiment, the narrow body lumen is a Fallopian tube and the inserting comprises inserting the partially extending inflatable body into an ostium of the Fallopian tube.
In at least one embodiment, the fully everting comprises everting the inflatable body so that it extends past a uterotubal junction.
In at least one embodiment, upon delivering the visualization instrument, a distal end of the visualization instrument is moved according to at least one of advancing and retracting the visualization instrument to visualize one or more target areas in the narrow body lumen.
In at least one embodiment, therapy is delivered through the opening of the inflatable body with the visualization instrument extending through the opening.
In at least one embodiment, therapy is delivered through the opening of the inflatable body without the visualization instrument extending therethrough.
In at least one embodiment, the process further includes retracting the inflatable body back into the outer shaft portion.
In at least one embodiment, the inflatable body is attached via a tether to a tube received within the outer shaft portion, and wherein retraction of the tube relative to the outer shaft portion retracts the inflatable body back into the outer shaft portion with assistance by the tether.
In at least one embodiment, the process further includes retracting the visualization instrument back into the outer shaft portion and retracting the inflatable body back into the outer shaft portion.
These and other features of the invention will become apparent to those persons skilled in the art upon reading the details of the apparatus, methods and systems as more fully described below.
In the course of the detailed description to follow, reference will be made to the attached drawings. These drawings show different aspects of the present invention an, where appropriate, reference numerals illustrating like structures, components, materials and/or elements in different figures are labeled similarly. It is understood that various combinations of the structures, components, materials and/or elements, other than those specifically shown, are contemplated and are within the scope of the present invention.
Before the present apparatus, methods and systems are described, it is to be understood that this invention is not limited to particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting.
Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limits of that range is also specifically disclosed. Each smaller range between any stated value or intervening value in a stated range and any other stated or intervening value in that stated range is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included or excluded in the range, and each range where either, neither or both limits are included in the smaller ranges is also encompassed within the invention, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the invention.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, the preferred methods and materials are now described. All publications mentioned herein are incorporated herein by reference to disclose and describe the methods and/or materials in connection with which the publications are cited.
It must be noted that as used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a tube” includes a plurality of such tubes and reference to “the lumen” includes reference to one or more lumens and equivalents thereof known to those skilled in the art, and so forth.
The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. The dates of publication provided may be different from the actual publication dates which may need to be independently confirmed.
In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present invention. It will be apparent, however, to one skilled in the art that the present invention may be practiced without limitation to some or all of these specific details. In other instances, well-known process steps have not been described in detail in order to not unnecessarily obscure the invention.
In certain embodiments, the present invention provides novel systems and methods for accurate real time-visualization, which dynamically diagnose malfunction of the fallopian tubes.
As part of a system, in at least some embodiment, provision of a single-use, disposable product and its associated procedure overcomes the many drawbacks encountered with current and attempted diagnostic approaches. The present inventions' more accurate, dynamic procedure may be conducted in an office of a gynecologist or a reproductive endocrinologist, who is typically the first and main point of contact for an infertility patient, understands the anatomy in question, and is better trained to dynamically change or repeat steps in the procedure if further clarification is needed. As a result, the number of office visits and costs to both the patient and hospital are significantly reduced, and at the same time, convenience to the parties involved is significantly increased. Furthermore, the high false positive rate of 20% to 40% encountered by the conventional diagnostic systems and procedures is also reduced by the present inventions' ability to directly visualize the fallopian tubes.
Preferred embodiments of the present invention recognize that to carry out certain initial steps of the inventive procedures, conventional diagnostic procedures may be relied upon to an extent. By way of example, certain inventive procedures require visualization of the openings (ostia) of the fallopian tubes in the uterus so that the tubes may be accessed. Those skilled in the art will recognize that although conventional hysteroscopes were primarily used to evaluate and maintain the health of a uterus, due to recent advancements in less invasive sterilization procedures such as Es sure and Adiana (during which the tube is purposely occluded), a large number (e.g., up to 7,500 for the Essure alone) of gynecologists and reproductive endocrinologists have adopted the hysteroscopes to visualize, and trans -vaginally access, the fallopian tube. The present invention proposes to use the hysteroscope's working channel, in certain embodiment of the present invention. Once gynecologists or reproductive endocrinologists own or lease a hysteroscope (and the associated capital equipment), they are free to use the inventive procedures of the present invention using the working channel of the hysteroscope because they are unlimited in terms of which procedures they may conduct using their hysteroscope. It is noteworthy that the working channel of any catheter, which can visualize and gain access to the ostia of the fallopian tubes within the uterus, may be utilized by the present invention.
In accordance with one embodiment, the present invention provides a hydraulic propulsion device that uses a working channel of a hysteroscope to access the ostia of the fallopian tubes. To this end,
Referring back to
Similarly, an electrical wire 118 runs from handle portion 102 through shaft portion 104 and is communicatively coupled to imaging subassembly 108. Electrical wire 118 enters a handle portion at an electrical access port 114, which connects to a wire lumen. Electrical wire 118 is placed inside the wire lumen, which also extends from handle portion 102 through shaft portion 104 to a location near image subassembly 108.
A seal-creating port 116 of
In addition to one or more of the ports and lumens described above, handle portion 102 preferably includes a housing 120 for holding in place coiled wire 118′, and a wire retrieval mechanism 122 to retrieve a hydraulically propelled wire in an operational state of apparatus 100 (which is shown as device 200 in
In another embodiment of the present invention, retrieval mechanism 122 includes an electronically activated reel, which electronically activates retrieval of the reel from the propelled state of the reel. In this embodiment, inventive devices include a pressure sensor for conveying a pressure measurement to the electrically activating reel mechanism such that if the pressure exceeds a predetermined value of pressure, then the electrically activating reel mechanism ceases to retrieve imaging subassembly 108. The pressure sensor may be designed to sense the pressure exerted on imaging subassembly 108, as it is retrieved from the narrow body lumen.
As part of shaft portion 104, seal-creating portion 106 (e.g., inflatable body) is located outside and distal to handle portion 102. In this configuration and when apparatus 100 is in an operational state, imaging portion 108 forms a seal with an inner diameter of the hydraulic propellant lumen, as shown in
Image subassembly 108 preferably includes an image sensor and a light source. The image sensor can be any object that is capable of sensing an image. In a preferred embodiment of the present invention, the image sensor includes at least one member selected from a group consisting of a charge coupled device (CCD), a complementary metal oxide semiconductor (CMOS) and an optical fiber. The light source includes a fiber optics light source or a light emitting diode (“LED”).
In certain embodiments of the present invention, an inflatable object contains the image sensor and the lighting source such that when the inflatable body is inflated, the imaging sensor is positioned near or at an approximate focal length away from the narrow body lumen to allow focused imaging of the narrow body lumen. In this embodiment, the focal length is associated with the imaging sensor. If the image sensor is a camera, then the focal length referred to herein is that of the camera.
As shown clearly in
Capsule 110 preferably encapsulates a wireless transmitter for wirelessly transmitting images captured by an imaging sensor of imaging subassembly 108. In certain preferred embodiments, capsule 110 of the present invention encapsulates a pressure sensor, which senses an amount of pressure being applied against the narrow body lumen to determine presence of blockages within the narrow body lumen.
Capsule 110 is substantially round and therefore avoids causing tissue trauma, which is a drawback of previously attempted direct visualization devices. Furthermore, capsule 110 has centered within it imaging portion 108. The positioning of imaging portion 108 within capsule 110 overcomes the drawback of the fallopian tube hanging over the distal end of the catheter, preventing an inadequate focal length and therefore unclear picture from being taken.
In one embodiment of the present invention, the capsule 110 is designed for encapsulating an inflatable body to enhance buoyancy of a portion of imaging subassembly 108 that is deployed inside the narrow body lumen during hydraulic propulsion. In such embodiments, capsule 110 of the present invention facilitates hydraulic propulsion of the propelled imaging portion as the inflatable body makes the capsule more easily carried by the hydraulic propellant.
In certain embodiments of the present invention, capsule 110 encapsulates a microgenerator, which uses the hydraulic propellant to provide power for the light source or the imaging sensor. In this embodiment, the microgenerator of the present invention converts hydraulic energy into electrical energy. This electrical energy is then used to power imaging portion 108 of the device. In other embodiments of the present invention, capsule 110 encapsulates optical fibers, which facilitate imaging by sending imaging signals from within the capsule to the imaging sensor that is located outside capsule 110 and distal to handle portion 102.
Although in connection with
To effectively maintain fallopian tubes, the present invention also offers non-hydraulically propelled imaging or therapeutic apparatus. In certain embodiments of the present invention, a guidewire and/or a catheter, which is positioned over the guidewire, facilitate imaging or therapy. In other embodiments, the guidewire lumen of the present invention facilitates therapeutic intervention.
As shown in
According to an embodiment of the present invention, however, guidewire 334 is preferably designed to provide light or is capable of sensing an image. To this end, guidewire 334 may contain illuminating fibers or imaging fibers. If an inventive catheter contains illuminating fibers, then the associated guide wire, which guides that catheter during operation, may include imaging fibers. Alternately, if the inventive catheter contains imaging fibers, then the associated guidewire 334 may include illuminating fibers. According to the present invention, in this manner, structures for carrying out illuminating and imaging functions may be distributed between a catheter and its associated guidewire. Separating a light source from an imaging sensor allows a device user to control the amount and angle of light needed to capture a clearer image (akin to a professional photographer having an external flash).
In certain embodiments of the present invention, guidewire 334 includes optical fibers for providing light to facilitate imaging, and may be made from fiber optics. In accordance with one embodiment of the present invention, during an operation state of apparatus with distal tip 326, guidewire 334 extends from a location outside the fallopian tube to another location inside the fallopian, such that light is conveyed from the location outside the fallopian tube to the location inside the fallopian tube. Having the source of the lighting remain outside of the fallopian tube will reduce heat exposure to the fallopian tubes.
In at least some embodiments of the inventive catheters, guidewire 334 includes a plurality of substantially transparent portions along a length of the guidewire. Each of the plurality of substantially transparent portions allow light to pass through. During an operational state of the catheter, each of the substantially transparent portions illuminate a plurality of different locations along the length of the fallopian tube that are adjacent to the substantially transparent portions. In this embodiment, a light emitting diode (“LED”) may be located at or around a guidewire' s tip and, as a result, incident light emanating from the LED exits from the substantially transparent portions and illuminates the tissue.
Inventive catheters may further include an image sensor located at a proximal end of a catheter shaft (e.g., 104 of
In alternate embodiments of the present invention, the catheters may further include an image sensor for sensing an image. In this embodiment, the image sensor is located at a distal end of a catheter shaft such that, during an operational of the catheter, an image of the fallopian tube sensed by the imaging sensor is conveyed by the imaging fibers or by electrical wires, which extend along a length of the catheter shaft, to a display unit that is located outside the fallopian tube. Although this configuration may increase the catheter's outer diameter, it provides a clearer image as the sensor is located closer to the image being taken.
Protective shield 330 or 330′ of
In other embodiments, inventive catheters may include a light source (e.g., light source 332 shown in
The present invention recognizes that during an imaging operation, fallopian tube tissue might fold over a light source and block illumination, and thereby, prevent proper illumination of a target location. In alternate embodiments, inventive catheters may include a light source that is protected by the substantially transparent protective shield. In this embodiment, the presence of a protective shield prevents the fallopian tube tissue from folding over and blocking the light source.
To reduce the risk of perforating the fallopian tube during an imaging operation as encountered by certain imaging attempts discussed above, inventive catheters may include a pressure sensor. In one implementation of this embodiment, the pressure sensor is located at a distal end of the guidewire and/or the catheter. During an imaging operation, the pressure sensor is capable of measuring a value of pressure exerted by the guidewire and/or the catheter against the fallopian tube. The pressure sensor may be communicatively coupled to a processor that provides an alert signal during an imaging operation. If, during an imaging operation, the value of pressure exerted by the guidewire and/or the catheter inside the fallopian tube is equal to or exceeds a predetermined unacceptable value of pressure, the processor provide the alert signal to a catheter' s user (e.g., activating a red warning light on the handle).
Inventive catheters may further include a guidewire lumen having defined therein a channel for the guidewire (e.g., guidewire 334 of
The therapy includes at least one member selected from a group consisting of an anti-inflammatory agent, bio-absorbable stent and a drug-coated inflatable body. In certain embodiments of the present invention, a liquid anti-inflammatory agent is delivered locally to a diseased site. Inflammation (likely caused by infection) is thought to be the leading cause of fallopian tube occlusion.
In those embodiments of the present invention where therapy includes a bio-absorbable stent, the stent may provide to the fallopian tube both mechanical support and a drug, which treats a local disease and prevents the occlusion from recurring. Optionally, the stent may be bioabsorbable. In such embodiments, after the stent is absorbed by the body and the disease is treated, the egg may uninterruptedly pass from the ovaries through the fallopian tube to the uterus.
With respect to the drug-coated inflatable body, during an operational state of the catheter, when the inflatable body (such as a balloon) is expanded, debris found within the fallopian tube may be dislodged by the force it takes to expand the balloon. Furthermore, the inflatable body may be positioned within a partial blockage. In this case, the expansion force will applies sufficient mechanical force to a blockage and serves to clear the blockage.
Furthermore, the drug-coating on the inflatable body (e.g., anti-inflammatory agent) prevents recurrence of those blockages for a time adequate to allow for conception. On the other hand, drug coated balloons used to treat coronary artery disease, face the challenge of a continuous blood flow which eventually rids the artery of the drug. Consequently, the patient only temporarily sees the benefit of the therapy, where treatment of coronary artery disease needs to last a lifespan of a patient. In contrast, the fallopian tubes are not inherently fluid filled. Therefore, the drug will last longer in the diseased region of the fallopian tube. Furthermore, the impact of the drug need only last for as long as it takes the patient to conceive (on average 0 to 12 months). If the drug dissipates and blockages do occur at some point after conception, those blockages do not cause any pain or discomfort to the patient.
Regardless of the manner in which distal tip 426 is implemented, it includes a shaft portion 404, one or more light sources 432 (labeled in
Furthermore, the conical shape may introduce less tissue trauma than the ovular-shaped protective shield.
At least some of the embodiments of the present invention also provide non-guide wire based diagnostic imaging apparatus or a non-guidewire lumen-based therapeutic intervention apparatus. A non-guidewire based diagnostic imaging apparatus includes a sensing lumen, a solution lumen and optionally a therapeutic lumen. The sensing lumen, in turn, includes a sensing portion and an inflatable portion. The sensing portion is capable of sensing information (e.g., imaging information) about the fallopian tube.
The solution lumen is designed to provide a solution, which facilitates sensing carried out by the sensing portion. The solution is also designed to flush the fallopian tube, ridding it of residual blood and mucous, which otherwise obscures the image. Furthermore, presence of the solution facilitates in the expansion of the fallopian tube and thereby reduces the chance of causing a perforation. Finally, therapeutic solutions used in the therapeutic apparatus are discussed above in greater detail.
During an operational state of the non-guidewire based diagnostic apparatus, the inflatable portion inflates to create a space around the sensing portion such that in presence of the solution, the sensing portion senses information regarding the fallopian tube, including but not limited to the presence of sterilization implants and naturally occurring blockages. This space allows for there to be an adequate focal length between the sensing portion and the fallopian tube wall to facilitate capturing a clear image (e.g., a clear image may be taken if the sensing portion is a standard optical camera or light-wave scattering optical system). However, if the sensing portion consists of a sound-wave imaging system, then the inflatable portion creates a seal so that the fallopian tube may be filled with a liquid medium, through which sound waves can propagate.
The sensing portion may include at least one member selected from a group consisting of light source, a camera, an acoustic imaging system and a scattered-light imaging system. Certain current techniques used for cardiovascular imaging (e.g., intravascular ultrasound (“IVUS”) and optical coherence tomography (“OCT”)) utilize light scattering and acoustic imaging techniques, but do not lend themselves to imaging fallopian tubes because of their rigidity. Furthermore, current cardiovascular IVUS catheters are not capable of creating a seal to facilitate imaging of a structure which is inherently non-fluid filled because in the absence of a medium, sound waves do not travel. It is noteworthy that because the fallopian tube is non-fluid filled, a seal must be created and the fallopian tube must be filled with a liquid medium, such as saline, before imaging using sound waves can occur. Further still, these catheters have relatively large dimensions which make it difficult to access the length of the narrow and tortuous fallopian tube.
To this end, the present invention proposes that catheter designs of IVUS and OCT may be modified in a manner consistent with the different relevant inventive catheters. Inventive catheters described herein are not limited to IVUS and OCT applications, and work well with other optical imaging techniques (e.g., imaging carried out by complementary metal oxide semiconductor (“CMOS”) or optical fiber). In accordance with preferred embodiments, inventive catheters include unique atraumatic tips and/or inflatable bodies as described below.
The imaging information collected by image portion 508 (
In accordance with at least one embodiment, inventive distal tips include a pressure sensor located at a distal end of a catheter and are designed to measure a value of pressure exerted by the catheter during an operational state of the apparatus. The pressure sensor features described above to alert a user of undue excessive pressure may also be incorporated in this embodiment.
Next, step 904 of
In this configuration, step 906 of
Then, another step 908 of
After step 908 and once a diseased portion of the fallopian tube or the fimbria of the fallopian tube is reached, step 910 of
Process 900 preferably comes to an end in step 912 of
It is noteworthy that steps 902 and 904 of
Next, step 1004 includes steering a guidewire through the channel to a target location within a lumen of a fallopian tube and the guidewire capable of providing light or imaging. By way of example, guidewire 334 in
In this configuration, step 1006 is carried out. Step 1006 includes placing a catheter, which facilitates imaging or therapy, over the guidewire. Depending on whether guidewire 334 of
Then, another step 1008 includes imaging the fallopian tube using the guidewire and the catheter. By way of example, imaging as required by this step is carried out by positioning guidewire 334 of
Furthermore, a protective shield (e.g., shield 330 of
After step 1008, step 1010 includes removing the guidewire from the channel.
Continuing with the guidewire example of
Next step 1012 includes introducing regional therapy to the fallopian tube through the channel. Therapy in this step is preferably introduced by way of an additional therapeutic catheter or in liquid form through the guidewire channel discussed above.
Process 1000 preferably comes to an end in step 1014, which involves treating the fallopian tube using the regional therapy or the catheter. Therapy in this step is preferably one therapeutic solution selected from a group consisting of applying an anti-inflammatory agent in liquid form, introducing a drug-coated balloon (e.g., coated with an anti-inflammatory), introducing a bio-absorbable stent and flushing with saline to remove debris from the fallopian tube.
It is noteworthy that steps 1002. 1010, 1012 and 1014 are optional and that the steps mentioned above need not be carried out in any particular order. Rather the sequence of steps described above represent a more preferred embodiment of the present invention. In one preferred embodiment of the present invention, another step may be added. Specifically, after imaging has concluded at the end of step 1008, another step, which includes retrieving the catheter from the fallopian tube, is more preferably carried out. Process 1000 can be carried out using any structure and is not limited to any structure shown in
Inflatable body 1106 is an elongated body and is inverted so as to pass into the shaft portion where it is bonded at an opposite end to tube 1108 at a distal end portion 1108D of tube 1108. Bonding/sealing may be performed by heat fusion and/or adhesives and/or other known bonding or sealing methods. Tube 1108 is rigid. A flexible tube 1110 is bonded to the distal end portion 1108D of rigid tube 1108, at a location distal to the location of bonding of the inflatable body 1106 to the rigid tube 1108. The flexible tube 1110 is flexibly configured so that it can easily bend to follow the curvatures of the natural body lumen when it is inserted therein. In the embodiment shown, the rigid tube 1108 is a stainless steel tube having an outside diameter of about 0.028″ and an inside diameter of about 0.020″. However, these materials and diameters may vary. For example, titanium or other biocompatible metal or rigid polymer could be substituted for stainless steel. The outside diameter may be a value in a range of from about 0.022″ to about 0.035″ and the inside diameter may be a value in a range of from about 0.015″ to about 0.028″. The flexible tube 1110 in the embodiment shown is a coiled wire tube made of wire filaments having an outside diameter of about 0.004″. The coiled wire tube has an inside diameter of about 0.020″. However, these diameters may vary. For example, the wire outside diameter may be a value in a range from about 0.002″ to about 0.006″, the outside diameter of flexible tube 1110 may be a value in a range of from about 0.022″ to about 0.035″ and the inside diameter may be a value in a range of from about 0.013″ to about 0.028″. Additionally, the flexible tube may be a tube made of a compliant material, such as Nylon, Pebax, or other material. Still further, the flexible tube need not be coiled, but could be braided, woven, or solid material, for example.
A visualization instrument 1112 is received through the lumen of the rigid tube 1108 and may be slid relative thereto to pass through the flexible tube 1110 and distally past the inflatable body 1106 as described in detail below. In the embodiment shown, visualization instrument is a fiberscope having an outside diameter of about 0.45 mm However, other visualization instruments may be substituted as long as they are dimensioned to be able to slide within the rigid 1108 and flexible 1110 tubes and distally thereof. The outside diameter may also vary, having a value in a range from about 0.30 mm to about 0.60 mm
Once in the initial deployment configuration, apparatus 1108 is vaginally inserted into the uterus (if it was not placed in the uterus prior to initially deploying) and the inflatable body 1106 is maneuvered into the ostium 18 of the fallopian tube. Once inflatable body 1106 has been passed into the ostium, while maintaining the pressurization, rigid tube 1108 is further distally advanced relative to shaft portion 1104 to fully deploy the inflatable body, as shown in
Having atraumatically established a pathway through the ostium 18 and past the uterotubal junction 19, the visualization instrument 1112 is next advanced distally relative to the shaft portion 1104, rigid tube 1108, flexible tube 1110 and inflatable body 1106, by pushing on the proximal end portion of the visualization instrument 1112 while holding the shaft portion 1104 and rigid tube 1108 relatively stationary. The distal end of the visualization instrument 1112 is advanced distally of the distal end of the inflatable body 1106 and flexible tube 1110 (
Although the embodiment of
Once the distal end portion of the apparatus has been placed within the uterus (which may be guided by visualization, by instrumentation, such as, but not limited to a hysteroscope, fluoroscopy, or other visualization mechanism), the apparatus is maneuvered by the surgeon to insert the partially deployed (partially everted inflatable body 1106 into the ostium 18 of the target Fallopian tube 12 during event 1304. This insertion may be guided by visualization provided by a hysteroscope, for example.
At event 1306 the inflatable member is fully deployed (fully everted) so that it extends past the uterotubal junction 19 in a manner as described above with regard to
Having atraumatically established a pathway through the ostium 18 and past the uterotubal junction 19, the visualization instrument 1112 is next advanced at event 1308 distally relative to the shaft portion 1104, rigid tube 1108, flexible tube 1110 and inflatable body 1106, by pushing on the proximal end portion of the visualization instrument 1112 while holding the shaft portion 1104 and rigid tube 1108 relatively stationary. The distal end of the visualization instrument 1112 is advanced distally of the distal end of the inflatable body 1106 and flexible tube 1110 (
Upon completion of the visualization procedures, the visualization instrument 1112 is retracted back into the shaft portion 1104; the rigid tube is retracted to also retract the inflatable member at event 1312. Apparatus 1100 can then be removed from the uterus at event 1314 and the post-operative procedures can be performed.
Once the distal end portion of the apparatus has been placed within the uterus (which may be guided by visualization, by instrumentation, such as, but not limited to a hysteroscope, fluoroscopy, or other visualization mechanism), the apparatus is maneuvered by the surgeon to insert the partially deployed (partially everted inflatable body 1106 into the ostium 18 of the target Fallopian tube 12 during event 1404. This insertion may be guided by visualization provided by a hysteroscope, for example.
At event 1406 the inflatable member is fully deployed (fully everted) so that it extends past the uterotubal junction 19 in a manner as described above with regard to
Having atraumatically established a pathway through the ostium 18 and past the uterotubal junction 19, a therapy treatment, such as those described above can be performed at event 1408. If the therapy applied is a liquid formulation, the visualization instrument 1112 can be advanced at event 1408 distally relative to the shaft portion 1104, rigid tube 1108, flexible tube 1110 and inflatable body 1106, by pushing on the proximal end portion of the visualization instrument 1112 while holding the shaft portion 1104 and rigid tube 1108 relatively stationary, and the liquid therapy can be pushed or pumped around the visualization instrument 1114 and within tube 1108 and tube 1110 to exit the tube 1110 at the distal end. The liquid therapy may optionally be used to distend the fallopian tube to further facilitate advancement of the visualization instrument 1112 through the fallopian tube and/or additional liquid such as saline or water may optionally be used.
In the case where the therapy to be delivered is not entirely liquid, such as in the deliverance of a stent or other non-liquid therapy, the visualization instrument 1114 can be removed from the apparatus and the lumen within the rigid tube 1108 and flexible tube 1110 can be used to deliver the therapy.
Upon completion of the therapy procedures, the visualization instrument, if present is retracted back into the shaft portion 1104. Optionally, the apparatus can be depressurized, but need not be. In any case, the rigid tube is retracted to also retract the inflatable member at event 1410. Apparatus 1100 can then be removed from the uterus at event 1412 and the post-operative procedures can be performed.
Although illustrative embodiments of this invention have been shown and described, other modifications, changes, and substitutions are intended. By way of example, the present invention discloses fallopian tubes as an exemplar of a narrow body lumen, which may undergo maintenance, and other anatomical structures, such as coronary arteries to other natural body tubes, may be similarly maintained Accordingly, it is appropriate that the invention be construed broadly and in a manner consistent with the scope of the disclosure. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, process, process step or steps, to the objective, spirit and scope of the present invention. All such modifications are intended to be within the scope of the claims appended hereto.
This application is a continuation-in-part application of co-pending U.S. application Ser. No. 14/929,989, filed Nov. 2, 2015, which is a division of U.S. application Ser. No. 13/979,691 (now U.S. Pat. No. 9,173,571) filed Jul. 15, 2013 under 35 USC §371 as a national stage of PCT/US2012/022619, filed 25 Jan. 2012, which claims priority from U.S. Provisional Application having Ser. No. 61/435,945, which was filed on Jan. 25, 2011, each of which applications and patent hereby incorporated herein, in their entireties, by reference thereto for all purposes and which applications we claim priority to. This application claims priority to co-pending U.S. Provisional Application No. 62/342,000, filed May 26, 2016, which is also hereby incorporated herein, in its entirety by reference thereto.
| Number | Date | Country | |
|---|---|---|---|
| 62342000 | May 2016 | US | |
| 61435945 | Jan 2011 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 13979691 | Jul 2013 | US |
| Child | 14929989 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 14929989 | Nov 2015 | US |
| Child | 15605407 | US |
